Cargando…

Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma

BACKGROUND: Renal cell carcinoma (RCC) is one of the most common aggressive malignant tumors in the urinary system, among which the clear cell renal cell carcinoma (ccRCC) is the most common subtype. The immune-related long noncoding ribonucleic acids (irlncRNAs) which are abundant in immune cells a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jian-Xuan, Xia, Qi-Dong, Liu, Chen-Qian, Xu, Jin-Zhou, Xun, Yang, Lu, Jun-Lin, Hu, Jia, Wang, Shao-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429034/ https://www.ncbi.nlm.nih.gov/pubmed/34512816 http://dx.doi.org/10.1155/2021/8800358

Ejemplares similares

Identification of a Twelve Epithelial-Mesenchymal Transition-Related lncRNA Prognostic Signature in Kidney Clear Cell Carcinoma
por: Xia, Qi-Dong, et al.
Publicado: (2022)

Construction and Characterization of n6-Methyladenosine-Related lncRNA Prognostic Signature and Immune Cell Infiltration in Kidney Renal Clear Cell Carcinoma
por: Chen, Zerong, et al.
Publicado: (2022)

Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma
por: Ma, Wei, et al.
Publicado: (2021)

Construction of an immune‐related LncRNA signature with prognostic significance for bladder cancer
por: Luo, Wen‐Jie, et al.
Publicado: (2021)

Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma
por: Zhang, Yue, et al.
Publicado: (2022)

Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis
por: Xue, Sheng, et al.
Publicado: (2022)

Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma
por: Zhong, Ming, et al.
Publicado: (2022)

Ferroptosis-associated lncRNA prognostic signature predicts prognosis and immune response in clear cell renal cell carcinoma
por: Lai, Jiayi, et al.
Publicado: (2023)

Novel Prognosis and Therapeutic Response Model of Immune-Related lncRNA Pairs in Clear Cell Renal Cell Carcinoma
por: Wang, Gang, et al.
Publicado: (2022)

A Computationally Constructed lncRNA-Associated Competing Triplet Network in Clear Cell Renal Cell Carcinoma
por: Zhang, Hui, et al.
Publicado: (2022)

Construction of an individualized clinical prognostic index based on ubiquitination-associated lncRNA in clear cell renal cell carcinoma patients
por: Liu, Kun, et al.
Publicado: (2022)

A Metastasis-Related lncRNA Signature Correlates With the Prognosis in Clear Cell Renal Cell Carcinoma
por: Dou, Qian, et al.
Publicado: (2021)

Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer
por: Xu, Minxian, et al.
Publicado: (2022)

Long Non-Coding RNA Profile Study Identifies an Immune-Related lncRNA Prognostic Signature for Kidney Renal Clear Cell Carcinoma
por: Sun, Zhuolun, et al.
Publicado: (2020)

Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma
por: Gu, Jun, et al.
Publicado: (2022)

Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature
por: Qi, Xiangjun, et al.
Publicado: (2021)

Identification and validation of fatty acid metabolism-related lncRNA signatures as a novel prognostic model for clear cell renal cell carcinoma
por: Shen, Cheng, et al.
Publicado: (2023)

Comprehensive analysis of lncRNA biomarkers in kidney renal clear cell carcinoma by lncRNA-mediated ceRNA network
por: Gong, Ke, et al.
Publicado: (2021)

Construction of an m6A‐related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2021)

Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma
por: Yu, JunJie, et al.
Publicado: (2021)

A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

A novel oxidative-stress related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

The lncRNA Fer1L4 is an adverse prognostic parameter in clear-cell renal-cell carcinoma
por: Cox, A., et al.
Publicado: (2020)

Identification of Hypoxia–Immune-Related Gene Signatures and Construction of a Prognostic Model in Kidney Renal Clear Cell Carcinoma
por: Bai, Shuheng, et al.
Publicado: (2022)

A novel prognostic signature of immune-related lncRNA pairs in lung adenocarcinoma
por: Liu, Yang, et al.
Publicado: (2021)

A Panel of Four-lncRNA Signature as a Potential Biomarker for Predicting Survival in Clear Cell Renal Cell Carcinoma
por: Liu, Haoran, et al.
Publicado: (2020)

Identification of a Three-Glycolysis-Related lncRNA Signature Correlated With Prognosis and Metastasis in Clear Cell Renal Cell Carcinoma
por: Li, Tinghao, et al.
Publicado: (2022)

A Notch signaling-related lncRNA signature for predicting prognosis and therapeutic response in clear cell renal cell carcinoma
por: Zhang, Lulu, et al.
Publicado: (2023)

A novel prognostic cancer-related lncRNA signature in papillary renal cell carcinoma
por: Chen, Binghai, et al.
Publicado: (2021)

Prognostic and immunological significance of calcium-related gene signatures in renal clear cell carcinoma
por: Liu, An, et al.
Publicado: (2022)

Prognostic significance of a 4-lncRNA glycolysis-related signature in oral squamous cell carcinoma
por: Wu, Liangyin, et al.
Publicado: (2022)

A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer
por: Yu, Zuhu, et al.
Publicado: (2022)

Construction of a prognostic glycolysis‐related lncRNA signature for patients with colorectal cancer
por: Zhong, Xinyang, et al.
Publicado: (2022)

Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma
por: Su, Yang, et al.
Publicado: (2021)

Construction and Validation of a Novel Cuproptosis-Related Seven-lncRNA Signature to Predict the Outcomes, Immunotherapeutic Responses, and Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma
por: Zhang, Haoxun, et al.
Publicado: (2023)

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning
por: Bai, Zhixun, et al.
Publicado: (2022)

The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
por: Zhang, Lishuo, et al.
Publicado: (2023)

Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma
por: Xu, Shengxian, et al.
Publicado: (2022)

Prognostic prediction of clear cell renal cell carcinoma based on lipid metabolism-related lncRNA risk coefficient model
por: Qu, GenYi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2qvh5c77ja3d6dfkn8q61coaik